Protein Kinase Cα Mediates Erlotinib Resistance in Lung Cancer Cells-Reference-Cited by-同舟云学术

Protein Kinase Cα Mediates Erlotinib Resistance in Lung Cancer Cells

Published:2015-02-27 Issue:5 Volume:87 Page:832-841
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Abera Mahlet B.,Kazanietz Marcelo G.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference60 articles.

1. EGFR-Targeted Therapy for Non-Small Cell Lung Cancer: Focus on EGFR Oncogenic Mutation

2. Protein Kinase C Isozymes, Novel Phorbol Ester Receptors and Cancer Chemotherapy

3. Characterization of the protein kinase C signal transduction pathway in cisplatin-sensitive and -resistant human small cell lung carcinoma cells;Basu;Cell Growth Differ,1996

4. Tyrosine Phosphorylation of Protein Kinase Cδ Is Essential for Its Apoptotic Effect in Response to Etoposide

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming Cancer Resistance: Strategies and Modalities for Effective Treatment;Biomedicines;2024-08-08

2. Signaling dynamics in coexisting monoclonal cell subpopulations unveil mechanisms of resistance to anti-cancer compounds;Cell Communication and Signaling;2024-07-26

3. Transcriptome analysis reveals PRKCA as a potential therapeutic target for overcoming cisplatin resistance in lung cancer through ferroptosis;Heliyon;2024-05

4. Protein kinase C signaling “in” and “to” the nucleus: Master kinases in transcriptional regulation;Journal of Biological Chemistry;2024-03

5. SIGNATURE-DRIVEN REPURPOSING OF MIDOSTAURIN FOR COMBINATION WITH MEK1/2 AND KRASG12C INHIBITORS IN LUNG CANCER;2023-06-26